Merck/Schering's Vytorin Priced At 22% Discount To Pfizer's Lipitor

The ezetimibe/simvastatin combination is priced at a 39% discount to the three highest doses of Merck's Zocor. Vytorin will launch in August at a wholesale acquisition cost of $2.34 per day.